Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer Genomics and Diagnostics, Cancer, Hypoxia, and Metabolism, Epigenetics and DNA Methylation, and Renal cell carcinoma treatment.
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
Mechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilities
Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinoma
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity
Cancer Evolution: A Multifaceted Affair
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma
NF-κB–Dependent Lymphoid Enhancer Co-option Promotes Renal Carcinoma Metastasis
VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function
Therapy-induced tumour secretomes promote resistance and tumour progression
Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer
Origins of Metastatic Traits
Hypoxia Signaling—License to Metastasize
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
Field Cancerization: Something New Under the Sun